Salgomed Competitors and Similar CompaniesClear all

Salgomed's competitors and similar companies include e-therapeutics, Absci, Domain Therapeutics and Quris.

	Salgomed Salgomed is a company that offers a platform for precision medicine that can be used to identify cancer drug targets and provide the clinical validation of candidate drugs.	e-therapeutics e-therapeutics is a computational drug discovery company.	Absci AbSci is a company that provides generative AI drug-creation solutions.	Domain Therapeutics Domain Therapeutics is a biopharmaceutical company.	Quris Quris Technologies is a biotechnology company that provides a platform for clinical prediction.
Founding Date	Founding Date 2012	Founding Date 2003	Founding Date 2011	Founding Date 2001	Founding Date 2020
Type	Type Private	Type Private	Type Public	Type Private	Type Private
Tags	Tags Technology biotech drug development machine learning pharma	Tags Technology biotech drug development pharma	Tags Technology artificial intelligence biotech drug development platform	Tags Technology biotech drug development pharma	Tags Technology artificial intelligence biotech drug development machine learning pharma platform
Locations	Locations HQ	Locations Long Hanborough, GB HQ Newcastle Upon Tyne, GB	Locations Vancouver, US HQ Belgrade, RS Zug, CH New York, US	Locations Illkirch-Graffenstaden, FR HQ Montréal, CA	Locations Tel Aviv-Yafo, IL HQ Boston, US
Employees	Employees 5	Employees 58	Employees 1561% increase	Employees 811% decrease	Employees 55
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $2.8m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A
Net income	Net income N/A	Net income (£14.9m) (FY, 2025)	Net income ($115.2m) (FY, 2025)	Net income N/A	Net income N/A
Funding
Latest funding round	Latest funding round $ 205k (almost 14 years ago)	Latest funding round N/A	Latest funding round N/A	Latest funding round $ 3.9m (almost 7 years ago)	Latest funding round $ 19m (over 4 years ago)
Total funding raised	Total funding raised N/A	Total funding raised $ 66.8m	Total funding raised $ 217.5m	Total funding raised $ 41.5m	Total funding raised $ 28m